BackEiger BioPharmaceuticals Overview

Eiger BioPharmaceuticals Cost of Revenue

Cost of Revenue analysis for EIGR.

Quarterly Cost of Revenue

$101000.00
↓ 70.72% YoY

As of Dec 31, 2023

Annual Cost of Revenue (TTM)

$644000.00
↓ 64.94% YoY

Trailing 12 months ending Dec 31, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin